WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2016

Apr 26, 2016

SEC Form 4/A — Form 4/A

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2015-04-24

Reporting Person: Green Eric Mark (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-04-24	Common Stock	A	30499.0000	$0.0000	Acquired	30499.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-04-24	Stock Option (Right to Buy)	$57.3800	A	79816.0000	Acquired	2025-04-24	Common Stock (79816.0000)	Direct
2015-04-24	Stock Option (Right to Buy)	$57.3800	A	53996.0000	Acquired	2025-04-24	Common Stock (53996.0000)	Direct
2015-04-24	Stock Option (Right to Buy)	$57.3800	A	164320.0000	Acquired	2020-04-24	Common Stock (164320.0000)	Direct

Footnotes

F1: This award vests in 2 installments beginning on 4/24/2018.

F2: Late filing due to administrative error.

F3: This award vests in 4 equal annual installments beginning on 2/23/2016.

F4: This award is 25% vested upon grant and an additional 25% vests on 2/24/16, 2/24/17 and 2/24/18.